The Advanced Medical Technology Association (AdvaMed) today released new survey results examining the first-year impact of the medical device excise tax. The survey found a significant reduction in jobs, R&D, and U.S. investment.
To provide information on the real-world impact of the tax in the first full year of implementation, AdvaMed conducted an online survey of member companies at the end of 2013. The survey responses were generalized to the industry as a whole based on the ratio of revenues of responding companies to revenues of the overall industry.
Read Full Article »